1.2K
Publications
63.9K
Citations
61
Authors
Denver
United States
Other names
RMCC
Rocky Mountain Cancer Centers is a healthcare institution in Denver, United States known for medicine, oncology, and radiation oncology.
1.2K
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo et al. · New England Journal of Medicine · 2018 · 3.7K citations · Full text
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.3K citations · Full text
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al. · New England Journal of Medicine · 2021 · 1.4K citations · Full text
Rows per page
1–5 of 1.2K
61
| Publications | Citations | H-Index | |
|---|---|---|---|
AL Rocky Mountain Cancer Centers | 230 | 15K | 48 |
JM Rocky Mountain Cancer Centers | 318 | 7.2K | 39 |
RM Rocky Mountain Cancer Centers | 184 | 14.1K | 35 |
RM Rocky Mountain Cancer Centers | 257 | 4.6K | 34 |
SD Rocky Mountain Cancer Centers | 102 | 5.2K | 30 |
Rows per page
1–5 of 61